Innovative Salivary Gland Biobank Offers Hope for Chronic Dry Mouth Treatment
Mayo Clinic scientists have developed a pioneering biobank of salivary gland tissue-organoids, opening new avenues for regenerating damaged glands and treating chronic dry mouth, especially in cancer patients.
Chronic dry mouth, medically known as xerostomia, affects millions worldwide and is often a debilitating side effect of salivary gland damage. This condition is particularly common among patients who have undergone radiation therapy for head and neck cancers, with nearly 70% experiencing permanent salivary gland damage. The resulting symptoms include difficulty chewing, tasting, speaking, swallowing, and an increased risk of tooth decay, significantly impairing quality of life.
In a groundbreaking development, researchers at Mayo Clinic have established the world’s first biobank of human salivary gland tissue-organoids. This biorepository provides a standardized collection of salivary gland samples, greatly advancing research efforts aimed at regenerating damaged glands and finding effective treatments for dry mouth. According to lead researcher Nagarajan Kannan, Ph.D., this resource addresses a critical barrier in the field—the limited availability of suitable, consistent salivary specimens for regenerative studies.
The biobank comprises samples from 208 donors and has already contributed to identifying biomarkers for saliva-producing cells and mapping the tissue origin of rare, self-renewing salivary cells. This platform enables scientists to develop personalized regenerative therapies, with potential to heal and grow new salivary gland tissue.
Additional research includes creating a radiation injury model to test regenerative approaches and exploring the cellular mechanisms underlying gland repair. This collaborative effort involves several departments at Mayo Clinic, including the Center for Regenerative Biotherapeutics.
The promise of this biobank extends beyond radiation-induced dry mouth, offering hope for patients who suffer from gland damage due to aging, medications, or diseases like diabetes, stroke, Alzheimer’s, and HIV/AIDS. With ongoing discoveries, future therapies may include cultivating regenerative cells and implanting new gland tissue, dramatically improving patient outcomes.
For more insights, refer to the study published in npj Regenerative Medicine: Establishment of salivary tissue-organoid biorepository. Source: https://medicalxpress.com/news/2025-05-salivary-gland-regenerative-biobank-combat.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Global Study Highlights Gaps and Changes in Maternal Healthcare in Australia, USA, and UK
A comprehensive international study highlights increasing maternal health risks, disparities, and evolving trends in pregnancy outcomes across Australia, the US, and UK, urging systemic improvements and equity-focused policies.
Genetic Link Between Salivary Enzyme and Type 2 Diabetes Uncovered
Recent research suggests that the number of copies of the salivary amylase gene (AMY1) may influence the risk of developing type 2 diabetes, offering new possibilities for early prediction and prevention.
Revolutionary Genomics Software Accelerates Cancer Research with 100-Fold Speed Increase
A new high-speed genomics software called Genome-Wide (GW) drastically increases the speed of genomic data analysis, opening new horizons for cancer research and understanding genetic alterations. Developed by Cardiff University, GW offers real-time visualization of large genomic changes, promising to accelerate discoveries and improve cancer diagnostics and treatments.
Active Music Therapy Interventions Show Greater Effectiveness for Pain Management Compared to Listening Alone
New research shows that active music therapy involving singing, instrument play, and relaxation techniques can significantly reduce pain more effectively than listening alone, offering a promising nonpharmacologic approach for hospitalized patients.